Cardinal Health, Inc. (CAH) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Available-for-sale Securities, Current |
| Current obligations | 43.90B USD | Liabilities, Current |
| Cash and equivalents | 4.86B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Available-for-sale Securities, Current |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | 17.30B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $43.90B | $4.86B | (m) | (m) | $17.30B | (m) |
| 2025-12-31 | (m) | $43.31B | $2.78B | (m) | (m) | $20.12B | (m) |
| 2025-09-30 | (m) | $40.27B | $4.59B | (m) | (m) | $17.56B | (m) |
| 2025-06-30 | (m) | $38.90B | $3.87B | (m) | (m) | $16.83B | (m) |
| 2025-03-31 | (m) | $36.66B | $3.33B | (m) | (m) | $16.16B | (m) |
| 2024-12-31 | (m) | $35.22B | $3.81B | (m) | (m) | $16.90B | (m) |
| 2024-09-30 | (m) | $34.68B | $2.87B | (m) | (m) | $15.62B | (m) |
| 2024-06-30 | (m) | $35.64B | $5.13B | (m) | (m) | $14.96B | (m) |
| 2024-03-31 | (m) | $36.31B | $3.72B | (m) | (m) | $17.28B | (m) |
| 2023-12-31 | (m) | $38.29B | $4.59B | (m) | (m) | $18.45B | (m) |
| 2023-09-30 | (m) | $35.06B | $3.85B | (m) | (m) | $16.99B | (m) |
| 2023-06-30 | (m) | $33.71B | $4.04B | (m) | (m) | $15.94B | (m) |
| 2023-03-31 | (m) | $32.50B | $3.99B | (m) | (m) | $16.62B | (m) |
| 2022-12-31 | (m) | $33.21B | $3.65B | (m) | (m) | $17.26B | (m) |
| 2022-09-30 | (m) | $31.56B | $3.49B | (m) | (m) | $15.89B | (m) |
| 2022-06-30 | (m) | $30.55B | $4.72B | (m) | (m) | $15.64B | (m) |
| 2022-03-31 | (m) | $28.71B | $2.36B | (m) | (m) | $15.49B | (m) |
| 2021-12-31 | (m) | $27.73B | $3.16B | (m) | (m) | $14.94B | (m) |
| 2021-09-30 | (m) | $26.50B | $2.46B | (m) | (m) | $14.72B | (m) |
| 2021-06-30 | (m) | $27.62B | $3.41B | (m) | (m) | $14.59B | (m) |
| 2021-03-31 | (m) | $25.32B | $3.50B | (m) | (m) | $14.33B | (m) |
| 2020-12-31 | (m) | $25.75B | $3.74B | (m) | (m) | $14.44B | (m) |
| 2020-09-30 | (m) | $24.02B | $2.75B | (m) | (m) | $13.44B | (m) |
| 2020-06-30 | (m) | $23.61B | $2.77B | (m) | (m) | $13.20B | (m) |
| 2020-03-31 | (m) | $24.67B | $2.33B | (m) | (m) | $12.81B | (m) |
| 2019-12-31 | (m) | $24.89B | $1.66B | (m) | (m) | $13.80B | (m) |
| 2019-09-30 | (m) | $22.55B | $1.21B | (m) | (m) | $12.46B | (m) |
| 2019-06-30 | (m) | $24.11B | $2.53B | (m) | (m) | $12.82B | (m) |
| 2019-03-31 | (m) | $23.92B | $3.44B | (m) | (m) | $12.62B | (m) |
| 2018-12-31 | (m) | $23.82B | $2.18B | (m) | (m) | $13.04B | (m) |
| 2018-09-30 | (m) | $23.06B | $2.04B | (m) | (m) | $12.48B | (m) |
| 2018-06-30 | (m) | $22.89B | $1.76B | (m) | (m) | $12.31B | (m) |
| 2018-03-31 | (m) | $21.43B | $2.17B | (m) | (m) | $11.96B | (m) |
| 2017-12-31 | (m) | $23.13B | $1.25B | (m) | (m) | $12.09B | (m) |
| 2017-09-30 | (m) | $22.41B | $1.18B | (m) | (m) | $12.12B | (m) |
| 2017-06-30 | (m) | $21.22B | $6.88B | $65.00M | (m) | $11.30B | (m) |
| 2017-03-31 | (m) | $19.80B | $1.37B | $128.00M | (m) | $11.64B | (m) |
| 2016-12-31 | (m) | $21.01B | $1.88B | $110.00M | (m) | $11.91B | (m) |
| 2016-09-30 | (m) | $20.00B | $2.00B | $108.00M | (m) | $10.92B | (m) |
| 2016-06-30 | (m) | $19.70B | $2.36B | $113.00M | (m) | $10.62B | (m) |
| 2016-03-31 | (m) | $19.39B | $2.60B | $105.00M | (m) | $10.91B | (m) |
| 2015-12-31 | (m) | $18.88B | $2.32B | $104.00M | (m) | $11.01B | (m) |
| 2015-09-30 | (m) | $17.78B | $2.97B | $107.00M | (m) | $9.76B | (m) |
| 2015-06-30 | (m) | $17.24B | $4.62B | $91.00M | (m) | $9.21B | (m) |
| 2015-03-31 | (m) | $16.39B | $3.18B | $35.00M | (m) | $9.16B | (m) |
| 2014-12-31 | (m) | $16.03B | $2.88B | $51.00M | (m) | $9.41B | (m) |
| 2014-09-30 | (m) | $14.90B | $2.47B | $25.00M | (m) | $8.07B | (m) |
| 2014-06-30 | (m) | $15.12B | $2.87B | $93.00M | (m) | $8.27B | (m) |
| 2014-03-31 | (m) | $13.15B | $3.04B | (m) | (m) | $8.03B | (m) |
| 2013-12-31 | (m) | $13.36B | $2.74B | (m) | (m) | $8.48B | (m) |
| 2013-09-30 | (m) | $12.51B | $2.75B | (m) | (m) | $7.28B | (m) |
| 2013-06-30 | (m) | $14.59B | $1.90B | (m) | (m) | $8.37B | (m) |
| 2013-03-31 | (m) | $14.47B | $2.31B | (m) | (m) | $8.33B | (m) |
| 2012-12-31 | (m) | $14.20B | $2.25B | (m) | (m) | $8.45B | (m) |
| 2012-09-30 | (m) | $14.67B | $2.44B | (m) | (m) | $8.11B | (m) |
| 2012-06-30 | (m) | $14.17B | $2.27B | (m) | (m) | $7.86B | (m) |
| 2012-03-31 | (m) | $14.85B | $2.41B | (m) | (m) | $8.22B | (m) |
| 2011-12-31 | (m) | $14.62B | $1.80B | (m) | (m) | $8.89B | (m) |
| 2011-09-30 | (m) | $13.80B | $2.01B | (m) | (m) | $7.50B | (m) |
| 2011-06-30 | (m) | $13.37B | $1.93B | (m) | (m) | $7.33B | (m) |
| 2011-03-31 | (m) | $13.76B | $1.96B | (m) | (m) | $7.72B | (m) |
| 2010-12-31 | (m) | $13.63B | $1.35B | (m) | (m) | $8.31B | (m) |
| 2010-09-30 | (m) | $12.45B | $2.71B | (m) | (m) | $7.09B | (m) |
| 2010-06-30 | (m) | $11.54B | $2.76B | (m) | (m) | $6.36B | (m) |
| 2010-03-31 | (m) | $12.75B | $2.64B | (m) | (m) | $7.21B | (m) |
| 2009-12-31 | (m) | $12.20B | $1.75B | (m) | (m) | $7.96B | (m) |
| 2009-09-30 | (m) | $12.15B | $1.58B | (m) | (m) | $6.86B | (m) |
| 2009-06-30 | (m) | $12.28B | $1.22B | (m) | (m) | $6.83B | (m) |
| 2009-03-31 | (m) | (m) | $971.80M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $582.60M | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | $387.40M | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $808.80M | (m) | (m) | (m) | (m) |
| 2007-06-30 | (m) | (m) | $796.70M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |